-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GwHBQz/vwM/NIBXE+/FkjDh6fzvcR9Nz8KnFw0OdvMXxyEUVotZ2dLwOExpzCRTJ 3qhwqFi2UOIjAeRkNnkXvw== 0001209191-10-046526.txt : 20100916 0001209191-10-046526.hdr.sgml : 20100916 20100916143605 ACCESSION NUMBER: 0001209191-10-046526 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100813 FILED AS OF DATE: 20100916 DATE AS OF CHANGE: 20100916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 101075772 BUSINESS ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND STATE: V8 ZIP: CH 4056 MAIL ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND ZIP: CH 4056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDENIX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001093649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450478605 BUSINESS ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-9800 MAIL ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: NOVIRIO PHARMACEUTICALS LTD DATE OF NAME CHANGE: 19990820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS PHARMA AG CENTRAL INDEX KEY: 0001030617 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 101075773 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 BUSINESS PHONE: 212-830-2474 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 FORMER NAME: FORMER CONFORMED NAME: NOVARTIS INC DATE OF NAME CHANGE: 19970114 4/A 1 c06043_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4/A 2010-08-13 2010-08-23 0001093649 IDENIX PHARMACEUTICALS INC IDIX 0001114448 NOVARTIS AG LICHSTRASSE 35 BASEL V8 CH 4002 SWITZERLAND 0 0 0 1 Indirect 10% owner 0001030617 NOVARTIS PHARMA AG LICHSTRASSE 35 BASEL V8 Ch 4002 SWITZERLAND 0 0 1 1 10% owner Common Stock 2010-08-13 4 P 0 36048 2.41 A 31360235 I See footnote Common Stock 2010-08-13 4 P 0 262 2.96 A 31360497 I See footnote Common Stock 2010-08-13 4 P 0 91 3.04 A 31360588 I See footnote Common Stock 2010-08-13 4 P 0 813 3.79 A 31361401 I See footnote These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment. This amendment is made to correct the date of the transaction. All other information in the Form 4 filed on August 23, 2010 remains the same. /s/ Felix Eichhorn 2010-09-16 /s/ Ramon Zapata-Gomez 2010-09-16 -----END PRIVACY-ENHANCED MESSAGE-----